ID
12007
Description
A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02034409. Principal Investigator: Daniel O Clegg, MD VA Salt Lake City Health Care System, Salt Lake City, UT.
Link
https://clinicaltrials.gov/show/NCT02034409
Keywords
Versions (1)
- 9/1/15 9/1/15 -
Uploaded on
September 1, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Osteoarthritis, Degenerative NCT02034409
Eligibility Osteoarthritis, Degenerative NCT02034409
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Description
Concurrent medical/arthritis condition(s), or any other illness per the opinion of the investigator, that could interfere with the evaluation of pain or efficacy
Data type
boolean
Alias
- UMLS CUI [1]
- C0205420
- UMLS CUI [2]
- C0012634
Description
Spine or hip pain of significant magnitude
Data type
boolean
Alias
- UMLS CUI [1]
- C0019559
Description
History of significant ligament or meniscal injury of the index joint
Data type
boolean
Alias
- UMLS CUI [1]
- C0435001
Description
Arthroscopy of the index knee within 6 months of study entry
Data type
boolean
Alias
- UMLS CUI [1]
- C1304878
Description
Unable to undergo MRI of the knee
Data type
boolean
Alias
- UMLS CUI [1]
- C0412714
Description
Pregnancy or lactation
Data type
boolean
Alias
- UMLS CUI [1]
- C0549206
Description
Corticosteroid treatment within 1 to 3 months prior to study entry
Data type
boolean
Alias
- UMLS CUI [1]
- C0001617
- UMLS CUI [2]
- C0087111
Description
Intra-articular injection of hyaluronic acid or congeners to the index knee within 6 months of study entry
Data type
boolean
Alias
- UMLS CUI [1]
- C0021488
Description
therapy; exclude
Data type
boolean
Alias
- UMLS CUI [1]
- C0087111
- UMLS CUI [2]
- C0332196
Description
Use of disease modifying anti-rheumatic medications and chronic tetracycline or its derivatives
Data type
boolean
Alias
- UMLS CUI [1]
- C0003191
Description
Exposure to glucosamine, chondroitin sulfate, or any other investigational treatment, within 1 month of study entry
Data type
boolean
Alias
- UMLS CUI [1]
- C0017720
- UMLS CUI [2]
- C0087111
Description
Use of any medical therapy, complementary or alternative regimens for the treatment of osteoarthritis within 7 days prior to study entry
Data type
boolean
Alias
- UMLS CUI [1]
- C0029408
- UMLS CUI [2]
- C0087111
Description
Initiation of any other medical or physical therapy, or muscle conditioning program, within 2 months prior to or during the study
Data type
boolean
Alias
- UMLS CUI [1]
- C0949766
Description
Unlikely to comply with study requirements
Data type
boolean
Alias
- UMLS CUI [1]
- C1321605
Similar models
Eligibility Osteoarthritis, Degenerative NCT02034409
- StudyEvent: Eligibility
C0029408 (UMLS CUI [2])
C0008902 (UMLS CUI [2])
C0012634 (UMLS CUI [2])
C0087111 (UMLS CUI [2])
C0332196 (UMLS CUI [2])
C0087111 (UMLS CUI [2])
C0087111 (UMLS CUI [2])